Company: PBH
Filing Date: 2025-02-06
Form Type: 10-Q
Source: 0001295947-25-000009
Chunk: 11

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-02-06
Form: 10-Q
Item: Item 2
Chunk 11
---
 countries have enacted legislation incorporating the agreed upon global minimum tax effective in 2024. This legislation has not and is not expected to have a material impact on our Consolidated Financial Statements.  As legislation becomes effective in more countries in which we do business, our taxes could increase and negatively impact our provision for income taxes.  We continue to monitor pending legislation and implementation by countries and to evaluate the potential impact on our business in future periods.

-23-

Results of Operations 

Three Months Ended December 31, 2024 compared to the Three Months Ended December 31, 2023

Total Segment Revenues

The following table represents total revenue by segment, including product groups, for the three months ended December 31, 2024 and 2023.

Three Months Ended December 31, Increase (Decrease)(In thousands)2024%2023%Amount%North American OTC HealthcareAnalgesics$29,314 10.1 $28,680 10.1 $634 2.2 Cough & Cold22,984 7.9 27,359 9.7 (4,375)(16.0)Women's Health53,686 18.6 53,076 18.9 610 1.1 Gastrointestinal42,521 14.6 38,919 13.7 3,602 9.3 Eye & Ear Care38,895 13.4 38,503 13.6 392 1.0 Dermatologicals28,546 9.8 26,603 9.4 1,943 7.3 Oral Care19,869 6.8 20,362 7.2 (493)(2.4)Other OTC3,119 1.1 3,063 1.1 56 1.8 Total North American OTC Healthcare238,934 82.3 236,565 83.7 2,369 1.0 International OTC HealthcareAnalgesics$1,668 0.6 $1,586 0.6 82 5.2 Cough & Cold6,347 2.2 5,814 2.1 533 9.2 Women's Health4,439 1.5 5,190 1.8 (751)(14.5)Gastro